Literature DB >> 23837223

The association between the HLA system and retinopathy development in patients with type 1 diabetes mellitus.

Snjezana Kastelan1, Martina Tomić, Jasminka Salopek-Rabatić, Josip Pavan, Adrian Lukenda, Marta Gotovac, Renata Zunec.   

Abstract

Duration of diabetes and chronic hyperglycemia are the most important risk factors in the pathogenesis of diabetic retinopathy (DR). However, there is increasing evidence suggesting that genetic factors may also contribute to its development. The aim of this study was to determine the role of the HLA system in the development of DR in patients with type 1 diabetes mellitus. Class II genes (DRB1, DQB1) were typed using the PCR-SSP method. Based on the fundus examination the patients were divided into two groups: one group with no or mild nonproliferative diabetic retinopathy (NPDR) and the other group with severe/very severe NPDR or proliferative diabetic retinopathy (PDR). The study confirms the influence of HLA genes in the development of DR in Croatian type 1 diabetic patients. In our patients, susceptibility to PDR appears to be primarily associated to DQB1*0201 with the relative risk, RR = 5.29 and DQB1*0302 (RR = 2.84). However, a strong positive correlation between DR and alles DRB1*0301 (RR = 2.12) and DRB1*0402 (RR = 3.01) was also found.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23837223

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  5 in total

1.  Assessment of the genetic basis of rosacea by genome-wide association study.

Authors:  Anne Lynn S Chang; Inbar Raber; Jin Xu; Rui Li; Robert Spitale; Julia Chen; Amy K Kiefer; Chao Tian; Nicholas K Eriksson; David A Hinds; Joyce Y Tung
Journal:  J Invest Dermatol       Date:  2015-02-19       Impact factor: 8.551

Review 2.  Biomarkers in diabetic retinopathy and the therapeutic implications.

Authors:  Katarzyna Zorena; Dorota Raczyńska; Krystyna Raczyńska
Journal:  Mediators Inflamm       Date:  2013-11-07       Impact factor: 4.711

Review 3.  Inflammation and pharmacological treatment in diabetic retinopathy.

Authors:  Snježana Kaštelan; Martina Tomić; Antonela Gverović Antunica; Jasminka Salopek Rabatić; Spomenka Ljubić
Journal:  Mediators Inflamm       Date:  2013-10-28       Impact factor: 4.711

4.  Body mass index and retinopathy in type 1 diabetic patients.

Authors:  Snježana Kaštelan; Jasminka Salopek Rabatić; Martina Tomić; Antonela Gverović Antunica; Spomenka Ljubić; Helena Kaštelan; Branko Novak; Darko Orešković
Journal:  Int J Endocrinol       Date:  2014-02-18       Impact factor: 3.257

Review 5.  Inflammatory and angiogenic biomarkers in diabetic retinopathy.

Authors:  Snježana Kaštelan; Ivana Orešković; Filip Bišćan; Helena Kaštelan; Antonela Gverović Antunica
Journal:  Biochem Med (Zagreb)       Date:  2020-08-05       Impact factor: 2.313

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.